StockNews.com upgraded shares of Elevance Health (NYSE:ELV – Free Report) from a buy rating to a strong-buy rating in a research note published on Monday morning. Other equities research analysts also recently issued reports about the company. Wells Fargo & Company increased their price target on Elevance Health from $557.00 to $600.00 and gave the […]